The Scientist

» Big Pharma and developmental biology

Most Recent

image: Taking Shots at Ebola

Taking Shots at Ebola

By | November 5, 2014

With an infusion of public and private resources and accelerated regulatory processes, a handful of companies are racing to develop a vaccine to curb the Ebola epidemic.

4 Comments

image: Speaking of Vision Science

Speaking of Vision Science

By | October 1, 2014

October 2014's selection of notable quotes

1 Comment

image: Precisely Placed

Precisely Placed

By | September 1, 2014

Vein patterns in the wings of developing fruit flies never vary by more than the width of a single cell.

3 Comments

image: Roche Buys Biotech for $8.3B

Roche Buys Biotech for $8.3B

By | August 27, 2014

The pharma giant strikes a deal to acquire InterMune, a Brisbane, California-based biotech with only one product—a treatment for a fatal lung disease.

0 Comments

image: Crayfish Blood Cells Make New Neurons

Crayfish Blood Cells Make New Neurons

By | August 13, 2014

Hemocytes can form neurons in adult crayfish, a study shows.

0 Comments

image: Roche Set to Buy RNAi Firm

Roche Set to Buy RNAi Firm

By | August 6, 2014

The Swiss pharmaceutical giant will reportedly pay $450 million for a Danish biotech company that develops drugs that silence microRNAs.

2 Comments

image: Arrested Development Makes for Long-Lived Worms

Arrested Development Makes for Long-Lived Worms

By | June 23, 2014

Starvation suspends cellular activity in C. elegans larvae and extends their lifespan. 

0 Comments

image: Autism-Hormone Link Found

Autism-Hormone Link Found

By | June 4, 2014

A study documents boys with autism who were exposed to elevated levels of testosterone, cortisol, and other hormones in utero.

1 Comment

image: The Telltale Tail

The Telltale Tail

By | May 1, 2014

A symbiotic relationship between squid and bacteria provides an alternative explanation for bacterial sheathed flagella.

0 Comments

image: Novartis and Glaxo Agree to Big Deal

Novartis and Glaxo Agree to Big Deal

By | April 22, 2014

The pharmaceutical companies announce a suite of asset swaps that drove up share prices and will reshape both.

2 Comments

Popular Now

  1. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  2. Sequencing Reveals Genomic Diversity of the Human Brain
  3. How Plants Evolved Different Ways to Make Caffeine
  4. What Sensory Receptors Do Outside of Sense Organs
RayBiotech